Skip to main content

NPS Pharma CEO: Market Recognizing Pipeline Potential

Francois Nader, CEO of NPS Pharmaceuticals, says the market is realizing the potential of its Gattex and Natpara drugs.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Scroll to Continue

TheStreet Recommends